Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Altered contractile function in heart failure

P P de Tombe1

  • 1Dept. of Physiology and Biophysics M/C 902, University of Illinois at Chicago 60607-7171, USA. pdetombe@uic.edu

Cardiovascular Research
|June 6, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nogo-A knockdown inhibits hypoxia/reoxygenation-induced activation of mitochondrial-dependent apoptosis in cardiomyocytes.

Journal of molecular and cellular cardiology·2011
Same author

Expression of slow skeletal troponin I in adult transgenic mouse heart muscle reduces the force decline observed during acidic conditions.

The Journal of physiology·2001
Same author

Losartan prevents contractile dysfunction in rat myocardium after left ventricular myocardial infarction.

American journal of physiology. Heart and circulatory physiology·2001
Same author

Ca(2+) activation of myofilaments from transgenic mouse hearts expressing R92Q mutant cardiac troponin T.

American journal of physiology. Heart and circulatory physiology·2001
Same author

Integration of cardiac myofilament activity and regulation with pathways signaling hypertrophy and failure.

Annals of biomedical engineering·2001
Same author

Myofilament lattice spacing as a function of sarcomere length in isolated rat myocardium.

American journal of physiology. Heart and circulatory physiology·2000

Congestive heart failure (CHF) involves decreased cardiac pump function due to reduced myocyte function. Understanding cellular changes like calcium handling and cytoskeleton alterations is key to developing new CHF treatments.

Area of Science:

  • Cardiology
  • Cellular Biology
  • Pathophysiology

Background:

  • Congestive heart failure (CHF) is a progressive, lethal condition marked by declining cardiac pump function.
  • End-stage CHF involves myocyte loss, extracellular matrix changes, ventricular remodeling, and impaired myocyte function.
  • Mechanisms driving decreased myocyte function in CHF remain incompletely understood.

Purpose of the Study:

  • This review focuses on the cellular mechanisms underlying decreased myocyte function in congestive heart failure.
  • To elucidate the specific cellular processes contributing to diminished cardiac contractility in CHF.

Main Methods:

  • Review of recent studies utilizing human myocardial tissue from cardiac transplantation.
  • Analysis of data from experimental animal models of congestive heart failure.

Related Experiment Videos

  • Examination of alterations in cellular processes within myocytes.

    • Main Results:

    • Studies suggest depressed myocyte function in CHF.
    • Potential mechanisms include alterations in intracellular calcium handling.
    • Other implicated factors are changes in myofilament function and the cytoskeleton.

    Conclusions:

    • The precise contribution of altered cellular processes to in vivo cardiac pump dysfunction in CHF is not yet established.
    • Further research into these cellular mechanisms is critical for developing novel therapeutic strategies against CHF.